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ifferential Diagnosis of Cardiac Masses
sing Contrast Echocardiographic Perfusion Imaging
ames N. Kirkpatrick, MD, Tiffany Wong, MD, James E. Bednarz, BS, RDCS,
irk T. Spencer, MD, FACC, Lissa Sugeng, MD, R. Parker Ward, MD, FACC,
eanne M. DeCara, MD, FACC, Lynn Weinert, BS, Thomas Krausz, MD, FRCPATH,
oberto M. Lang, MD, FACC
hicago, Illinois
OBJECTIVES We investigated the usefulness of echocardiographic contrast perfusion imaging in differen-
tiating cardiac masses.
BACKGROUND Two-dimensional echocardiography is the primary diagnostic modality for cardiac masses.
However, differentiation between the different types of cardiac masses may be difficult at
times. We hypothesized that echocardiographic contrast perfusion imaging would differen-
tiate the neo-vascularization of malignancies from the avascularity of thrombi and the sparse
vascularity of stromal tumors.
METHODS Sixteen patients with cardiac masses underwent power-modulation imaging after echocar-
diographic intravenous contrast administration. Pixel intensities in the mass and an adjacent
section of myocardium were analyzed visually and by dedicated software. All masses had a
pathologic diagnosis or resolved after anticoagulation. In a subset of patients, video-intensity
curves of contrast replenishment in the mass and myocardium over time were generated. The
post-impulse steady-state pixel intensity (A) and initial rate of contrast replenishment after
impulse () were compared with an index of blood vessel area on pathology.
RESULTS In seven of 16 patients, contrast enhancement resulted in greater pixel intensity in the mass than
in the adjacent myocardium. All of these masses were classified pathologically as malignant (n 
6) or benign and vascular (n 1). Nine masses demonstrated decreased pixel intensity, compared
with the myocardium, and were diagnosed pathologically as myxomas (n  2) or thrombi (n 
5), or they resolved with anticoagulation (n 2). For the subset of patients,  correlated with the
vessel area index (r  0.60).
CONCLUSIONS Echocardiographic contrast perfusion imaging aids in the differentiation of cardiac masses.
Compared with the adjacent myocardium, malignant and vascular tumors hyper-enhanced,
whereas stromal tumors and thrombi hypo-enhanced. (J Am Coll Cardiol 2004;43:1412–9)
© 2004 by the American College of Cardiology Foundationa
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pwo-dimensional echocardiography is regarded as the pri-
ary diagnostic imaging technique for the evaluation of
ardiac mass lesions, with a diagnostic sensitivity of 93% for
ransthoracic echocardiography and 97% for transesopha-
eal echocardiography (1). However, differentiation be-
See page 1420
ween different types of cardiac masses, including thrombi
nd benign and malignant tumors, may be difficult at times.
et, this distinction provides important diagnostic and
rognostic information and guides therapeutic decision-
aking.
Microbubble contrast agents have been used with two-
imensional echocardiography to delineate the myocardium-
lood interface, to define intracavitary structures, and to eval-
ate myocardial perfusion (2–4). The development of second-
eneration contrast agents and new imaging techniques, such
From the Adult Noninvasive Cardiac Imaging Laboratories, Section of Cardiology;
nd the Department of Pathology, University of Chicago, Chicago, Illinois.
Manuscript received June 23, 2003; revised manuscript received August 26, 2003,
cccepted September 9, 2003.s power modulation, have greatly improved the echocardio-
raphic ability to assess myocardial perfusion. Qualitative and
uantitative methods now exist to differentiate reliably between
ormal, ischemic, and infarcted myocardial tissues by their
evel of echocardiographic contrast perfusion (5,6).
We hypothesized that perfusion imaging could also be
sed to help characterize the vascularity of cardiac masses.
n particular, we hypothesized that enhancement with
chocardiographic contrast imaging would differentiate the
eo-vascularization of a malignancy or vascular tumor from
he avascularity of a thrombus and the sparse vascularity of
benign stromal tumor and that the level of enhancement
ould correlate with the diagnosis made by the gold
tandards of pathologic analysis or resolution of the mass
fter anticoagulant therapy.
ETHODS
atient population. Sixteen patients (12 females and 4
ales; age range 19 to 84 years) with intracardiac or
ericardial masses underwent perfusion imaging with echo-
ardiographic contrast at the University of Chicago’s Non-
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April 21, 2004:1412–9 Contrast Echocardiographic Perfusion of Cardiac Massesnvasive Imaging Laboratory from September 1999 to Jan-
ary 2003. This study was approved by the Institutional
eview Board of the University of Chicago Hospitals.
chocardiographic imaging and analysis. After a slow
ntravenous push (0.6 to 1.0 ml) of Optison (Amersham
ealth, Princeton, New Jersey) or continuous intravenous
nfusion (infusion rate adjusted for optimal enhancement of the
ass) of Definity (Bristol-Meyers Squibb, New York, New
ork), the masses were imaged using gray-scale power mod-
lation (SONOS 5500, Philips Medical Systems, Andover,
assachusetts) in either real-time or a triggered mode with a
ow mechanical index (0.1), and the gain and compression
ettings were optimized for visualization of perfusion of the
ass (typically within a range of 40% to 80%). The focus was
et at the level of the mass. Whenever a mass demonstrated
erfusion with echocardiographic contrast, an ultrasound im-
ulse of high mechanical index (1.0 to 1.6) was transmitted for
our up to 10 frames, as needed, to destroy microbubbles
ithin the mass. This prevented the recording of “false-positive
erfusion” due to a saturation artifact secondary to high gain
ettings. Perfusion of the mass was then confirmed by visual-
zing gradual contrast replenishment of the mass after the
igh-mechanical index impulse.
Contrast enhancement was assessed both visually, by an
able 1. Contrast Perfusion and Pathologic Diagnosis of Cardiac
Patient
Number Location of Mass
Mean P
Intensity
of Ma
1 Pulmonary artery, extension from mediastinal
mass encasing great vessels
11
2 RA, originating in SVC 15
3 RV apex 3.7
4 LV apex 25
5 Pleura and pericardium near apical-lateral LV 15
6 Apical pericardium 30
7 Apical pericardium 18
8 LA, attached to fossa ovalis 10
9 LA side of interatrial septum 7.7
10 RA free wall near IVC 5.5
11 RA free wall 4.8
12 LV apex, pedunculated 0.1
13 LV apex 0.2
14 LV apex 7.1
15 LV apex 4.1
16 LV apex 20
Abbreviations and Acronyms
A  post-impulse maximal steady-state intensity level
ROI  region of interest
VAI  vessel area indexVC  inferior vena cava; LA  left atrial; LV  left ventricle/ventricular; RA  right axperienced reader familiar with contrast perfusion imaging,
nd using dedicated software (Qlab, Philips Medical Sys-
ems). Because absolute pixel intensity is subject to varia-
ions in contrast infusion rates and depth of masses, the
erfusion in a mass is meaningfully assessed only in relation
o the perfusion in the adjacent myocardium. A discrete
egion of interest (ROI) was drawn both within the central
art of each mass and within a section of adjacent ventric-
lar myocardium. Care was taken not to draw ROIs in areas
f the myocardium that demonstrated a lack of perfusion.
he ROI locations were adjusted to correct for translational
otion. The mean pixel intensities within the ROIs were
easured for each frame in at least two cardiac cycles. The
ifference between the mean pixel intensity of the mass and
hat of the adjacent myocardium was computed.
To assess the interobserver variability of the visual inter-
retation of mass perfusion, three blinded expert readers
ere asked to assess the level of contrast within the mass.
heir responses were compared with those of the original
eader, with a weighted kappa statistic.
In addition, three less experienced readers with no train-
ng in contrast perfusion imaging were shown non-contrast
mages of each mass and diagnosed the mass as malignancy/
ascular tumor, stromal tumor, or thrombus. They were
hen shown contrast perfusion images of each mass and
gain made a diagnosis. These answers were compared
gainst the gold standard of pathologic diagnosis, and a
ilcoxon matched-pairs signed-rank test was used to assess
he incremental benefit of contrast in improving diagnostic
ccuracy.
ses
Mean Pixel
Intensity (dB)
of Myocardium Pathology
8.2 Anaplastic large-cell lymphoma
11 Follicular thyroid carcinoma
1 Malignant peripheral nerve sheath tumor
19 Hemangioma
6.5 Lung adenocarcinoma
16 Poorly differentiated adenocarcinoma, unknown
primary
15 Well-differentiated adenocarcinoma of the lung
16 Myxoma
7.8 Myxoma
6.5 Resolution demonstrated on echocardiogram
after 2 months of anticoagulation
8.1 Thrombus (resected for anticoagulation
contraindication)
6.5 Thrombus (resected for anticoagulation
contraindication)
17 Thrombus on autopsy
29 Resolution demonstrated on follow-up
echocardiogram
13 Thrombus (resected during coronary artery
bypass)
29 Mural thrombus on autopsyMas
ixel
(dB)
sstrial; SVC  superior vena cava.
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Contrast Echocardiographic Perfusion of Cardiac Masses April 21, 2004:1412–9athologic correlation. The echocardiographic findings
ere then compared with the pathologic diagnosis for each
ass (n  14) or the results of follow-up imaging studies
emonstrating resolution of the mass after anticoagulant
herapy (n  2).
uantitative analysis of perfusion. In a subset of seven
atients, further quantitative analysis was performed. Video
oops were triggered to acquire end-systolic frames. The
ean pixel intensity after a high mechanical impulse was
hen simultaneously calculated frame by frame for both the
ass and a section of adjacent myocardium and fitted with
he following exponential function of time (7):
y  A · (1e · t)
here A reflects the post-impulse maximal steady-state
ntensity level (a surrogate measure for vascular volume) and
represents the initial rate of contrast replenishment after
he high-mechanical index impulse (reflecting the velocity
f blood flow) (8). The A and  values for each mass were
ubtracted from the A and  values for the section of
djacent myocardium to account for differences in contrast
nfusion rate and depth of mass.
The biopsy specimens for these seven masses were stained
ith a variety of monoclonal antibodies directed against anti-
ens found in the endothelium, including factors VIII, CD31,
igure 1. (A) A mass filling the right atrium (apical five-chamber view). (
he adjacent myocardium. (C) There was no enhancement of the mass or th
ubbles, ruling out “false-positive perfusion” of the mass. (D) The biopsy sp
ith CD31 antibody. (E) Perfusion curves of video intensity over time
yocardium.nd CD34. The slide that demonstrated the clearest staining of dascular structures with the least amount of background stain-
ng was analyzed to determine a vessel area index (VAI) as
ollows. For each biopsy specimen, the power of magnification
either 10 or 40) that demonstrated the best image of the
essels for accurate cross-sectional area measurement was
hosen. In specimens for which the 10 power was used, all
essels were measured in a total of 10 fields to obtain an
ccurate representation of the entire biopsy specimen. The
0 power was used in the case of smaller sized vessels, and a
otal of 25 fields were measured. Using a dedicated software
rogram (Leica AS LMD, version 3.1, Leica Microsystems,
annockburn, Illinois), lines were drawn to outline the lumen
f vessels in each field, and the cross-sectional area of each
essel was computed in m2. To compare the sizes of the
essels between specimens, the diameter of greatest dimension
as computed in m using the same software program for 50
andom vessels in each specimen. The average vessel diameter
nd range for each specimen were calculated. For each biopsy
pecimen, the total cross-sectional area of all vessels measured
as calculated and divided by the total area covered in all the
elds viewed to obtain the VAI.
ESULTS
chocardiographic imaging and analysis. Seven masses
he mass hyper-enhanced with echocardiographic contrast, compared with
cent myocardium after a high-mechanical index impulse destroyed contrast
n diagnosis was follicular thyroid carcinoma. The blood vessels are stained
nstrated greater values for A and  for the mass than for the adjacentB) T
e adja
ecime
demoemonstrated enhancement with echocardiographic con-
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April 21, 2004:1412–9 Contrast Echocardiographic Perfusion of Cardiac Massesrast, both visually and on quantitative analysis. In each case,
he mean pixel intensity over the cardiac cycle of the mass
as higher than that of the adjacent myocardium. Two
asses demonstrated partial and/or incomplete enhance-
ent with contrast upon visual inspection; the mean pixel
ntensity was lower than that of the myocardium. Seven of
he masses failed to enhance upon visual inspection and had
lower mean pixel intensity than that of the myocardium
Table 1). The weighted kappa values for interobserver
ariability on visual assessment of perfusion ranged from
.75 to 0.84.
Contrast perfusion imaging improved the less experi-
nced readers’ accuracy in differentiating between malignan-
y/vascular tumor, stromal tumor, and thrombus. The total
umber of correct diagnoses for all three readers increased
rom 34 to 41 (of 48 possible) with the addition of contrast
erfusion imaging. The Wilcoxon matched-pairs signed-
ank test yielded a two-tailed p value of 0.06.
athologic correlation. The seven patients who had car-
iac masses demonstrating greater enhancement than the
djacent myocardium were diagnosed with malignant or
ighly vascular tumors by pathologic analysis. The two
asses that enhanced partially on visual inspection were
onfirmed pathologically to be myxomas (n  2). Of the
even masses that failed to enhance, five were pathologically
onfirmed to be thrombi at the time of cardiac surgery,
igure 2. (A) A mass adjacent to the lateral wall of the left ventricle (apic
o the adjacent myocardium. (C) There was no enhancement of the mass
icrobubbles. (D) A biopsy specimen stained with factor VIII antibody de
erfusion curves of video intensity over time demonstrated greater valueshereas two resolved on anticoagulation therapy (Table 1). iuantitative analysis of perfusion. Video-intensity curves
or contrast perfusion, echocardiographic images, and patho-
ogic specimens for the subset of seven masses are shown in
igures 1 through 5. Table 2 details pathologic diagnoses,
essel size range, pathologic VAI, and differences between
he A and  values of mass and myocardium for the subset.
elative to the adjacent myocardium, malignant (n 4) and
ascular benign (n  1) tumors demonstrated a more rapid
ncrease in perfusion and higher steady-state perfusion: the
ean difference in  between each mass and section of
djacent myocardium (mean massmyocardium) was 1.3/s
range 0.1 to 2.7), and the mean difference in A between
ach mass and section of adjacent myocardium (mean
Amassmyocardium) was 6.8 dB (range 4.0 to 13). The
hrombi did not perfuse, as illustrated by the flat line in
igure 3. The correlation coefficients for Amassmyocardium
nd VAI and for massmyocardium and VAI were 0.36 and
.60, respectively.
ISCUSSION
sing contrast echocardiography, our study found qualita-
ive and quantitative differences in the gray scale between
he levels of perfusion in various types of cardiac masses and
ections of adjacent myocardium. These differences were
etected using power modulation and dedicated video-
r-chamber view). (B) There was hyperenhancement of the mass, relative
e adjacent myocardium after a high-mechanical index impulse destroyed
trated extensive vascularity in a poorly differentiated adenocarcinoma. (E)
and  for the mass than for the adjacent myocardium.al fou
or th
mons
for Antensity detection software. Malignant or highly vascular
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Contrast Echocardiographic Perfusion of Cardiac Masses April 21, 2004:1412–9umors demonstrated greater enhancement than the adja-
ent myocardium. Myxomas demonstrated partial perfusion
n visual inspection and quantitatively less perfusion than
he myocardium. The thrombi in this study demonstrated
o perfusion. With the aid of contrast, perfusion imaging
dentified three pericardial malignancies—an area that has
raditionally been a challenge to evaluate with echocardiog-
aphy. The addition of contrast perfusion to standard imaging
emonstrated a trend toward improving the ability of readers
ithout training in this technique to diagnose cardiac masses,
lthough the number of data points likely precluded detection
f a statistically significant improvement. In a subset of seven
asses, the difference in the rate of increase in pixel intensity
fter a high mechanical impulse between the mass and adjacent
yocardium (massmyocardium) demonstrated a better corre-
ation with VAI in the pathologic specimens, as compared with
he difference in the maximum steady-state pixel intensity
etween the mass and myocardium (Amassmyocardium).
The etiology of cardiac masses presents a differential
iagnosis with important prognostic and therapeutic impli-
ations. Benign tumors generally portend a good prognosis.
lthough malignant primary cardiac tumors, if discovered
arly, are potentially curable with surgical resection (9),
tudies have consistently found a very poor prognosis and
ow overall rates of respectability (10–12). Thrombi may
igure 3. (A) A left ventricular apical mass (apical four-chamber view).
yocardium demonstrated enhancement. (C) There was no enhancemen
estroyed the contrast agent. (D) The surgical specimen demonstrated no s
E) Perfusion curves of video intensity over time demonstrated no increase
ithin the myocardium.resent with catastrophic embolization and warrant surgical pemoval in some cases, but they often resolve with nonin-
asive treatment (13). Although multiple echocardiographic
riteria are used to define cardiac masses (14–18), there are
requent reports in the medical literature of diagnostic errors
19–21). Misclassifications can lead to unfortunate out-
omes from an unnecessary surgical procedure or inappro-
riate exposure to the risks of anticoagulation.
Myocardial tissue is highly vascular (capillary density on
he order of 2,500 to 3,000/mm3) (22), but most malignan-
ies have abnormal neo-vascularization that supplies rapidly
rowing tumor cells, often in the form of highly concen-
rated, dilated vessels, as depicted in Figures 1, 2, and 5 (23).
he total blood-carrying capacity of these vessels is likely to
e in excess of that of the adjacent myocardium. Stromal
umors, such as myxomas, have a poor blood supply.
hrombi are generally avascular (Fig. 3). Sensitive measures
f tissue perfusion should therefore be able to detect
ifferences between neo-vascularized malignant or highly
ascular cardiac tumors, poorly vascularized stromal tumors,
vascular thrombi, and normal myocardium.
Contrast echocardiography to characterize myocardial
erfusion has benefited in recent years from the develop-
ent of new microbubble agents that can be administered
ntravenously at a constant rate to achieve a steady-state
oncentration. Application of a high-mechanical index im-
The mass showed no enhancement with contrast, whereas the adjacent
he mass or adjacent myocardium after a high-mechanical index impulse
g with CD34 antibody and minimal cellularity, consistent with thrombus.
deo intensity in the mass from baseline, whereas video intensity increased(B)
t of t
tainin
in viulse leads to increased microbubble destruction; the rate of
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April 21, 2004:1412–9 Contrast Echocardiographic Perfusion of Cardiac Masseseplenishment () and maximum steady-state concentration
A) of microbubbles in tissue after the impulse can be
easured as video intensity, reflecting the degree of blood
ow (24,25). The off-line use of a computer program to
etect and quantify replenishment after microbubble de-
truction within a cardiac structure has been applied to
ssessment of wall motion (26) and myocardial perfusion
27,28). The application of such a program to evaluate
erfusion within a cardiac mass versus an adjacent section of
yocardium is, as far as we know, unique to this study.
Microbubble contrast and pulse-inversion imaging of
arge vessels has been used to differentiate benign from
alignant tumors in the liver (29,30), but power-
odulation imaging allows more sensitive detection of
maller vessels and a potentially improved correlation with
athologic blood vessel assessments than has previously
een demonstrated (31). In our subset of seven patients, we
sed power-modulation contrast imaging to characterize the
elationships between blood vessel volume, rate of blood
ow in the mass, and a pathologic measure of vessel area by
omparing the differences in A and  between the mass and
djacent myocardium with VAI. massmyocardium corre-
ated reasonably well with VAI, probably because the dilated
eovessels of the malignant and highly vascular tumors in
he subset filled more quickly with contrast agent than
id the normal vessels of the adjacent myocardium.
igure 4. (A) A left ventricular apical mass (apical four-chamber view). (B
C) There was no enhancement of the mass or adjacent myocardium after a
pecimen was diagnosed as a hemangioma with abundant, dilated, thick-w
urves of video intensity over time demonstrated greater values for A andAmassmyocardium did not correlate well with VAI, perhaps wecause the relatively small portion of a mass that is
nalyzed to determine VAI may not reflect the level of
erfusion detected by contrast perfusion imaging. Con-
ersely, some of the specimens contained vessels with very
mall lumens, and perhaps the resolution of the pixel-
ntensity detection program was unable to detect the con-
ribution of these small vessels to the maximum pixel
ntensity. Furthermore, as Ellegala et al. (32) have demon-
trated in contrast perfusion imaging of malignant gliomas
n rat brains, detection of the volume and velocity of blood
ow in the tumor relative to the adjacent tissue may depend
n size of the tumor.
By differentiating malignant/highly vascular tumors from
enign tumors and thrombi, echocardiographic contrast
erfusion imaging may aid in the early identification and
ppropriate treatment of cardiac masses. Primary cardiac
umors are rare, with an estimated incidence of 0.0017% to
.28% (33). Thrombi and metastases are far more common
nd constitute the main elements of the differential diagno-
is, unless located in the atria (suggesting myxoma) (34).
yperenhancement, signaling probable malignancy, in a
ardiac tumor may facilitate early recognition and resection,
r may steer treatment planning toward palliation for
ertain patients who wish to avoid invasive and probably
utile interventions. A complete lack of enhancement, sig-
aling thrombus, would be an indication for anticoagulation
mass hyper-enhanced with contrast, relative to the adjacent myocardium.
-mechanical index impulse destroyed the contrast agent. (D) The surgical
vessels, demonstrated by staining with factor VIII antibody. (E) Perfusion
the mass than for the adjacent myocardium.) The
high
alled
 forith a follow-up imaging study to evaluate resolution and
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Contrast Echocardiographic Perfusion of Cardiac Masses April 21, 2004:1412–9ould prevent unnecessary cardiac surgery. A further appli-
ation is the detection and evaluation of malignant or highly
ascular tumors or metastases within the myocardium that
o not protrude into cardiac chamber cavities. Objective
yperenhancement of one area of the myocardium may raise
he suspicion for intramyocardial tumor infiltration.
tudy limitations. Although myxomas appeared to dem-
nstrate partial enhancement on visual inspection, thrombi
nd myxomas could not be differentiated objectively on the
asis of average pixel intensity in the mass relative to
yocardium. An assessment of Amassmyocardium and
massmyocardium was performed in only seven patients.
ecause of the differences in depth of the masses and the
iffering amounts of perfusion between different patients,
igure 5. (A) A computed tomographic scan of the chest with contrast dem
arenchyma (yellow arrow). (B) Apical four-chamber view of the left ven
yellow arrow). (C) The LV apical mass failed to enhance with contrast
emonstrated large vascular channels (yellow arrow). (D) There was no en
mpulse destroyed the microbubbles. (E) The biopsy specimen of the extr
hannels stained with CD34 antibody. Lacking pathologic correlation, the
AI and does not appear in Table 2. (F) Perfusion curves of video intensi
djacent myocardium and no increase in intensity from baseline for the in
able 2. Subset of Masses With Quantitative Echocardiographic
Patient
Number Pathologic Diagnosis
V
2 Follicular thyroid carcinoma in RA (Fig. 1)
6 Poorly differentiated adenocarcinoma in apical
pericardium (Fig. 2)
12 Thrombus in LV apex (Fig. 3)
4 Hemangioma in LV apex (Fig. 4)
7 Adenocarcinoma of lung in apical pericardium (Fig. 5)
11 Thrombus on RA free wall
1 Lymphoma in pulmonary artery
 maximum steady-state pixel intensity (dB);   rate of increase in pixel intensit
2f high-power fields (m ). Other abbreviations as in Table 1.e were unable to compare pixel intensity between the
ifferent types of masses and instead had to compare the
ifferences in perfusion relative to the adjacent myocardium.
ot all of our pathologic specimens contained myocardial
issue, and we were unable to evaluate any possible effect
hat differences in myocardial VAI between patients may
ave had on A and .
onclusions. We found that quantification of echocardio-
raphic perfusion imaging of cardiac masses with gray-scale
ower modulation facilitates the differential diagnosis of
ardiac masses. Malignant and highly vascular tumors be-
ame visually hyper-enhanced and demonstrated quantita-
ively more perfusion than the adjacent myocardium. Stro-
al tumors demonstrated partial enhancement and less
ating an intracardiac mass (white arrow) and a hypodense area in the lung
r (LV) apical mass (white arrow) and the mass extrinsic to the LV apex
reas the extrinsic mass hyper-enhanced, relative to the myocardium, and
ment of the masses or adjacent myocardium after a high-mechanical index
mass showed a well-differentiated adenocarcinoma with multiple vascular
ardiac mass was not included in the comparison of contrast perfusion with
r time demonstrated greater values for A and  for the mass than for the
diac mass. The intracardiac mass was presumed to be a thrombus.
sion
Diameter
ge in m
ange) VAI Amassmyocardium massmyocardium
2.0–68) 0.024 4 1.1
2.0–159) 0.013 5.9 0.5
2.0–36) 0.0010 6.3 1.1
2.0–608) 0.040 5.3 2.5
2.0–56) 0.017 13 2.7
1.0–5.0) 0.000017 4.7 0.51
14–454) 0.020 5.9 0.12
; VAI  vessel area index: total cross-sectional area of blood vessels (m2)/total areaonstr
tricula
, whe
hance
insic
intrac
ty ove
tracarPerfu
essel
Avera
(r
10 (
17 (
5.2 (
63 (
11 (
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April 21, 2004:1412–9 Contrast Echocardiographic Perfusion of Cardiac Masseserfusion than the adjacent myocardium. Thrombi failed to
nhance. With the application of contrast perfusion imag-
ng, there was a trend toward improving the ability of
eaders with no training in this technique to differentiate
etween these types of tumors. In a subset of seven patients,
he rate of increase in pixel intensity over time correlated
ith the cross-sectional vessel area of the pathologic spec-
men. This technique could be easily applied in echocardio-
raphic laboratories with contrast perfusion imaging
apabilities.
eprint requests and correspondence: Dr. Roberto M. Lang,
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